Difference between revisions of "Part:BBa K5382151"
Chenyuyanyan (Talk | contribs) |
Chenyuyanyan (Talk | contribs) |
||
Line 3: | Line 3: | ||
<partinfo>BBa_K5382151 short</partinfo> | <partinfo>BBa_K5382151 short</partinfo> | ||
− | The z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In studies, the z domain is used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues. The 4z domain, a tetramer of the z domain, has also been shown to be able to construct EVs displaying antibodies< | + | The z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In studies, the z domain is used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues. The 4z domain, a tetramer of the z domain, has also been shown to be able to construct EVs displaying antibodies<sup>[1]</sup>, with similar binding activity as the z domain. |
+ | |||
+ | ===References=== | ||
+ | [1] Oscar P B Wiklander;Doste R Mamand;Dara K Mohammad;Wenyi Zheng;Rim Jawad Wiklander;Taras Sych;Antje M Zickler;Xiuming Liang;Heena Sharma;Andrea Lavado;Jeremy Bost;Samantha Roudi;Giulia Corso;Angus J Lennaárd;Manuchehr Abedi Valugerdi;Imre Mäger;Evren Alici;Erdinc Sezgin;Joel Z Nordin;Dhanu Gupta;André Görgens;Samir El Andaloussi.Antibody-displaying extracellular vesicles for targeted cancer therapy.[J].Nature biomedical engineering,2024,() | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here |
Latest revision as of 05:42, 1 October 2024
4z domain-protein domain
The z domain refers to a synthetic protein domain that has the ability to bind to the Fc region of immunoglobulin G (IgG). In studies, the z domain is used to construct extracellular vesicles (EVs) that can display antibodies, so that these EVs can bind specific antibodies through the z domain on their surface, so as to achieve targeted delivery to specific cells or tissues. The 4z domain, a tetramer of the z domain, has also been shown to be able to construct EVs displaying antibodies[1], with similar binding activity as the z domain.
References
[1] Oscar P B Wiklander;Doste R Mamand;Dara K Mohammad;Wenyi Zheng;Rim Jawad Wiklander;Taras Sych;Antje M Zickler;Xiuming Liang;Heena Sharma;Andrea Lavado;Jeremy Bost;Samantha Roudi;Giulia Corso;Angus J Lennaárd;Manuchehr Abedi Valugerdi;Imre Mäger;Evren Alici;Erdinc Sezgin;Joel Z Nordin;Dhanu Gupta;André Görgens;Samir El Andaloussi.Antibody-displaying extracellular vesicles for targeted cancer therapy.[J].Nature biomedical engineering,2024,()
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 487